Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 377

1.

Conceptual framework for establishing the African Stroke Organization.

Akinyemi R, Sarfo F, Abd-Allah F, Ogun Y, Belo M, Francis P, Mateus MB, Bateman K, Naidoo P, Charway-Felli A, Akpalu A, Wahab K, Napon C, Arulogun O, Ebenezer AA, Ekeng G, Scola G, Hamzat K, Zimba S, Ossou-Nguiet PM, Ademokoya J, Adebayo P, Ayele BA, Vaz DC, Ogbole G, Barasukan P, Melifonwu R, Onwuekwe I, Belson S, Damasceno A, Okubadejo N, Njamnshi AK, Ogeng'o J, Walker RW, Diop AG, Ogunniyi A, Kalaria R, Sandercock P, Davis S, Brainin M, Ovbiagele B, Owolabi M.

Int J Stroke. 2020 Feb 6:1747493019897871. doi: 10.1177/1747493019897871. [Epub ahead of print]

PMID:
32026763
2.

How can the World Stroke Organization (WSO) optimize education in stroke medicine around the world? Report of the 2018 WSO Global Stroke Stakeholder Workshop.

Gubitz G, Saini M, Belson S, Sahathevan R, Sandercock P.

Int J Stroke. 2019 Oct;14(8):803-805. doi: 10.1177/1747493019874726. Epub 2019 Sep 10.

PMID:
31506027
3.

Fluoxetine and Fractures After Stroke: Exploratory Analyses From the FOCUS Trial.

Dennis M, Forbes J, Graham C, Hackett ML, Hankey GJ, House A, Lewis S, Lundström E, Sandercock P, Mead G.

Stroke. 2019 Nov;50(11):3280-3282. doi: 10.1161/STROKEAHA.119.026639. Epub 2019 Aug 20.

PMID:
31426731
4.

Top 10 global educational topics in stroke: A survey by the World Stroke Organization.

Saini M, Belson S, Lahiff-Jenkins C, Sandercock P.

Int J Stroke. 2019 Oct;14(8):843-849. doi: 10.1177/1747493019855892. Epub 2019 Jun 10.

PMID:
31180814
5.

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial.

Al-Shahi Salman R, Minks DP, Mitra D, Rodrigues MA, Bhatnagar P, du Plessis JC, Joshi Y, Dennis MS, Murray GD, Newby DE, Sandercock PAG, Sprigg N, Stephen J, Sudlow CLM, Werring DJ, Whiteley WN, Wardlaw JM, White PM; RESTART Collaboration.

Lancet Neurol. 2019 Jul;18(7):643-652. doi: 10.1016/S1474-4422(19)30184-X. Epub 2019 May 22.

6.

The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: statistical analysis plan for a randomised controlled trial.

Al-Shahi Salman R, Murray GD, Dennis MS, Newby DE, Sandercock PAG, Sprigg N, Sudlow CLM, Werring DJ, White PM, Whiteley WN.

Trials. 2019 Mar 25;20(1):183. doi: 10.1186/s13063-019-3270-2.

7.

Clinical diagnosis of TIA or minor stroke and prognosis in patients with neurological symptoms: A rapid access clinic cohort.

Graham C, Bailey D, Hart S, Hutchison A, Sandercock P, Doubal F, Sudlow C, Farrall A, Wardlaw J, Dennis M, Whiteley W.

PLoS One. 2019 Mar 19;14(3):e0210452. doi: 10.1371/journal.pone.0210452. eCollection 2019.

8.

Stroke in China: advances and challenges in epidemiology, prevention, and management.

Wu S, Wu B, Liu M, Chen Z, Wang W, Anderson CS, Sandercock P, Wang Y, Huang Y, Cui L, Pu C, Jia J, Zhang T, Liu X, Zhang S, Xie P, Fan D, Ji X, Wong KL, Wang L; China Stroke Study Collaboration.

Lancet Neurol. 2019 Apr;18(4):394-405. doi: 10.1016/S1474-4422(18)30500-3. Review.

PMID:
30878104
9.

World Stroke Day.

Sandercock P.

Stroke. 2018 Dec;49(12):2809. doi: 10.1161/STROKEAHA.118.023089. No abstract available.

PMID:
30571450
10.

Effect of IV alteplase on the ischemic brain lesion at 24-48 hours after ischemic stroke.

Mair G, von Kummer R, Morris Z, von Heijne A, Bradey N, Cala L, Peeters A, Farrall AJ, Adami A, Potter G, Sandercock PAG, Lindley RI, Wardlaw JM; IST-3 Collaborative Group.

Neurology. 2018 Nov 27;91(22):e2067-e2077. doi: 10.1212/WNL.0000000000006575. Epub 2018 Oct 26.

11.

World Stroke Day - a day of global action.

Sandercock P.

Int J Stroke. 2018 Oct;13(8):779. doi: 10.1177/1747493018799263. No abstract available.

PMID:
30328802
12.

Visual Rating Scales of White Matter Hyperintensities and Atrophy: Comparison of Computed Tomography and Magnetic Resonance Imaging.

Ferguson KJ, Cvoro V, MacLullich AMJ, Shenkin SD, Sandercock PAG, Sakka E, Wardlaw JM.

J Stroke Cerebrovasc Dis. 2018 Jul;27(7):1815-1821. doi: 10.1016/j.jstrokecerebrovasdis.2018.02.028. Epub 2018 Mar 23.

13.

The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial.

Al-Shahi Salman R, Dennis MS, Murray GD, Innes K, Drever J, Dinsmore L, Williams C, White PM, Whiteley WN, Sandercock PAG, Sudlow CLM, Newby DE, Sprigg N, Werring DJ; RESTART collaborators.

Trials. 2018 Mar 5;19(1):162. doi: 10.1186/s13063-018-2542-6.

14.

Cut stroke in half: Polypill for primary prevention in stroke.

Brainin M, Feigin V, Martins S, Matz K, Roy J, Sandercock P, Teuschl Y, Tuomilehto J, Wiseman A.

Int J Stroke. 2018 Aug;13(6):633-647. doi: 10.1177/1747493018761190. Epub 2018 Feb 20. Review.

PMID:
29461155
15.

How to do high-quality clinical research 1: First steps.

Sandercock P, Whiteley W.

Int J Stroke. 2018 Feb;13(2):121-128. doi: 10.1177/1747493017750923. Epub 2018 Jan 4.

PMID:
29299959
16.

Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trials.

Hacke W, Lyden P, Emberson J, Baigent C, Blackwell L, Albers G, Bluhmki E, Brott T, Cohen G, Davis SM, Donnan GA, Grotta JC, Howard G, Kaste M, Koga M, von Kummer R, Lansberg MG, Lindley RI, Olivot JM, Parsons M, Sandercock PA, Toni D, Toyoda K, Wahlgren N, Wardlaw JM, Whiteley WN, Del Zoppo G, Lees KR; Stroke Thrombolysis Trialists’ Collaborators Group.

Int J Stroke. 2018 Feb;13(2):175-189. doi: 10.1177/1747493017744464. Epub 2017 Nov 24. Erratum in: Int J Stroke. 2018 Feb;13(2):NP3.

PMID:
29171359
17.

Blood pressure variability and leukoaraiosis in acute ischemic stroke.

Dickie DA, Aribisala B, Mair G, Berge E, Lindley RI, Sandercock P, von Kummer R, von Heijne A, Peeters A, Cala L, Farrall A, Morris Z, Bradey N, Potter G, Adami A, Wardlaw JM.

Int J Stroke. 2018 Jul;13(5):473-480. doi: 10.1177/1747493017729267. Epub 2017 Sep 5.

PMID:
28872448
18.

Controversies in Thrombolysis.

Sandercock PAG, Ricci S.

Curr Neurol Neurosci Rep. 2017 Aug;17(8):60. doi: 10.1007/s11910-017-0767-5. Review.

19.

Increasing value and reducing waste in stroke research.

Berge E, Al-Shahi Salman R, van der Worp HB, Stapf C, Sandercock P, Sprigg N, Macleod MR, Kelly PJ, Nederkoorn PJ, Ford GA; European Stroke Organisation Trials Network Committee.

Lancet Neurol. 2017 May;16(5):399-408. doi: 10.1016/S1474-4422(17)30078-9. Review.

PMID:
28414653
20.

Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.

Sandercock PA, Leong TS.

Cochrane Database Syst Rev. 2017 Apr 4;4:CD000119. doi: 10.1002/14651858.CD000119.pub4. Review.

21.

Cerebral White Matter Hypoperfusion Increases with Small-Vessel Disease Burden. Data From the Third International Stroke Trial.

Arba F, Mair G, Carpenter T, Sakka E, Sandercock PAG, Lindley RI, Inzitari D, Wardlaw JM; IST-3 Trial Collaborators.

J Stroke Cerebrovasc Dis. 2017 Jul;26(7):1506-1513. doi: 10.1016/j.jstrokecerebrovasdis.2017.03.002. Epub 2017 Mar 15.

PMID:
28314624
22.

Arterial Obstruction on Computed Tomographic or Magnetic Resonance Angiography and Response to Intravenous Thrombolytics in Ischemic Stroke.

Mair G, von Kummer R, Adami A, White PM, Adams ME, Yan B, Demchuk AM, Farrall AJ, Sellar RJ, Sakka E, Palmer J, Perry D, Lindley RI, Sandercock PA, Wardlaw JM; IST-3 Collaborative Group.

Stroke. 2017 Feb;48(2):353-360. doi: 10.1161/STROKEAHA.116.015164. Epub 2016 Dec 22.

23.

Effect of Right Insular Involvement on Death and Functional Outcome After Acute Ischemic Stroke in the IST-3 Trial (Third International Stroke Trial).

Sposato LA, Cohen G, Wardlaw JM, Sandercock P, Lindley RI, Hachinski V; IST-3 Expert Reading Panel and the IST-3 Collaborative Group.

Stroke. 2016 Dec;47(12):2959-2965. Epub 2016 Nov 15.

PMID:
27895298
24.

Mortality after thrombolysis - Authors' reply.

Berge E, Cohen G, Wardlaw JM, Sandercock PAG, Whiteley WN.

Lancet Neurol. 2016 Dec;15(13):1305. doi: 10.1016/S1474-4422(16)30280-0. No abstract available.

PMID:
27839642
25.

Interpretation of the evidence for the efficacy and safety of statin therapy.

Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, Blumenthal R, Danesh J, Smith GD, DeMets D, Evans S, Law M, MacMahon S, Martin S, Neal B, Poulter N, Preiss D, Ridker P, Roberts I, Rodgers A, Sandercock P, Schulz K, Sever P, Simes J, Smeeth L, Wald N, Yusuf S, Peto R.

Lancet. 2016 Nov 19;388(10059):2532-2561. doi: 10.1016/S0140-6736(16)31357-5. Epub 2016 Sep 8. Review. Erratum in: Lancet. 2017 Feb 11;389(10069):602.

26.

Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 Trials.

Lees KR, Emberson J, Blackwell L, Bluhmki E, Davis SM, Donnan GA, Grotta JC, Kaste M, von Kummer R, Lansberg MG, Lindley RI, Lyden P, Murray GD, Sandercock PA, Toni D, Toyoda K, Wardlaw JM, Whiteley WN, Baigent C, Hacke W, Howard G; Stroke Thrombolysis Trialists’ Collaborators Group.

Stroke. 2016 Sep;47(9):2373-9. doi: 10.1161/STROKEAHA.116.013644. Epub 2016 Aug 9.

27.

Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial.

Berge E, Cohen G, Roaldsen MB, Lundström E, Isaksson E, Rudberg AS, Slot KB, Forbes J, Smith J, Drever J, Wardlaw JM, Lindley RI, Sandercock PA, Whiteley WN; IST-3 Collaborative Group.

Lancet Neurol. 2016 Sep;15(10):1028-34. doi: 10.1016/S1474-4422(16)30139-9. Epub 2016 Jul 20.

PMID:
27450474
28.

The forecast for future clinical trials and clinical trialists-Storms or sunshine?

Klijn CJ, Sandercock PA.

Int J Stroke. 2016 Oct;11(7):738-40. doi: 10.1177/1747493016655362. Epub 2016 Jun 17.

PMID:
27316456
29.

Author Response.

Wardlaw JM, Brazzelli M, Chappell F, Dennis MS, Sandercock PA.

Neurology. 2016 Feb 16;86(7):697. No abstract available.

PMID:
27303783
30.

Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis.

Whiteley WN, Emberson J, Lees KR, Blackwell L, Albers G, Bluhmki E, Brott T, Cohen G, Davis S, Donnan G, Grotta J, Howard G, Kaste M, Koga M, von Kummer R, Lansberg MG, Lindley RI, Lyden P, Olivot JM, Parsons M, Toni D, Toyoda K, Wahlgren N, Wardlaw J, Del Zoppo GJ, Sandercock P, Hacke W, Baigent C; Stroke Thrombolysis Trialists' Collaboration.

Lancet Neurol. 2016 Aug;15(9):925-933. doi: 10.1016/S1474-4422(16)30076-X. Epub 2016 Jun 8.

PMID:
27289487
31.

IST-3 stroke trial data available.

Sandercock P, Wardlaw J, Lindley R, Whiteley W, Cohen G.

Lancet. 2016 May 7;387(10031):1904. doi: 10.1016/S0140-6736(16)30414-7. No abstract available.

PMID:
27203647
32.

Methods to improve patient recruitment and retention in stroke trials.

Berge E, Stapf C, Al-Shahi Salman R, Ford GA, Sandercock P, van der Worp HB, Petersson J, Dippel DW, Krieger DW, Lees KR; ESO Trials Network Committee.

Int J Stroke. 2016 Aug;11(6):663-76. doi: 10.1177/1747493016641963. Epub 2016 Apr 26. Review.

PMID:
27118766
33.

European Stroke Organisation (ESO) guidelines for prophylaxis for venous thromboembolism in immobile patients with acute ischaemic stroke.

Dennis M, Caso V, Kappelle LJ, Pavlovic A, Sandercock P; European Stroke Organisation.

Eur Stroke J. 2016 Mar;1(1):6-19. doi: 10.1177/2396987316628384. Epub 2016 Mar 1.

34.

Exploring the role and function of trial steering committees: results of an expert panel meeting.

Harman NL, Conroy EJ, Lewis SC, Murray G, Norrie J, Sydes MR, Lane JA, Altman DG, Baigent C, Bliss JM, Campbell MK, Elbourne D, Evans S, Sandercock P, Gamble C.

Trials. 2015 Dec 30;16:597. doi: 10.1186/s13063-015-1125-z.

35.

Effect of X-Ray Attenuation of Arterial Obstructions on Intravenous Thrombolysis and Outcome after Ischemic Stroke.

Mair G, von Kummer R, Lindley RI, Sandercock PA, Wardlaw JM; IST-3 Collaborative Group.

PLoS One. 2015 Dec 23;10(12):e0145683. doi: 10.1371/journal.pone.0145683. eCollection 2015.

36.

Effect of alteplase on the CT hyperdense artery sign and outcome after ischemic stroke.

Mair G, von Kummer R, Morris Z, von Heijne A, Bradey N, Cala L, Peeters A, Farrall AJ, Adami A, Potter G, Cohen G, Sandercock PA, Lindley RI, Wardlaw JM; IST-3 Collaborative Group.

Neurology. 2016 Jan 12;86(2):118-25. doi: 10.1212/WNL.0000000000002236. Epub 2015 Dec 9.

37.

Review and prioritization of stroke research recommendations to address the mission of the World Stroke Organization: a call to action from the WSO Research Committee.

Sacco RL, Sandercock P, Endres M, Feigin V, Pandian J, Shinohara Y, Spence JD.

Int J Stroke. 2015 Oct;10 Suppl A100:4-9. doi: 10.1111/ijs.12625. No abstract available.

PMID:
26502969
38.

Effects of Blood Pressure and Blood Pressure-Lowering Treatment During the First 24 Hours Among Patients in the Third International Stroke Trial of Thrombolytic Treatment for Acute Ischemic Stroke.

Berge E, Cohen G, Lindley RI, Sandercock P, Wardlaw JM, Sandset EC, Whiteley W.

Stroke. 2015 Dec;46(12):3362-9. doi: 10.1161/STROKEAHA.115.010319. Epub 2015 Oct 20.

39.

Peter Sandercock: Worst mistake was hubris.

Sandercock P.

BMJ. 2015 Oct 14;351:h5403. doi: 10.1136/bmj.h5403. No abstract available.

PMID:
26466928
40.

Erratum: An assessment of the cost-effectiveness of magnetic resonance, including diffusion-weighted imaging, in patients with transient ischaemic attack and minor stroke: a systematic review, meta-analysis and economic evaluation.

Wardlaw J, Brazzelli M, Miranda H, Chappell F, McNamee P, Scotland G, Quayyum Z, Martin D, Shuler K, Sandercock P, Dennis M.

Health Technol Assess. 2015 Sep;18(27):369-70. doi: 10.3310/hta18270-c201509. No abstract available.

41.

The Clots in Legs Or sTockings after Stroke (CLOTS) 3 trial: a randomised controlled trial to determine whether or not intermittent pneumatic compression reduces the risk of post-stroke deep vein thrombosis and to estimate its cost-effectiveness.

Dennis M, Sandercock P, Graham C, Forbes J; CLOTS (Clots in Legs Or sTockings after Stroke) Trials Collaboration, Smith J.

Health Technol Assess. 2015 Sep;19(76):1-90. doi: 10.3310/hta19760.

42.

Which stroke patients gain most from intermittent pneumatic compression: further analyses of the CLOTS 3 trial.

Dennis M, Graham C, Smith J, Forbes J, Sandercock P; CLOTS trial collaboration.

Int J Stroke. 2015 Oct;10 Suppl A100:103-7. doi: 10.1111/ijs.12598. Epub 2015 Aug 26.

PMID:
26307376
43.

Does personalized medicine exist and can you test it in a clinical trial?

Sandercock PA.

Int J Stroke. 2015 Oct;10(7):994-9. doi: 10.1111/ijs.12597. Epub 2015 Aug 18. Review.

PMID:
26282857
44.

ABCD2 score and secondary stroke prevention: meta-analysis and effect per 1,000 patients triaged.

Wardlaw JM, Brazzelli M, Chappell FM, Miranda H, Shuler K, Sandercock PA, Dennis MS.

Neurology. 2015 Jul 28;85(4):373-80. doi: 10.1212/WNL.0000000000001780. Epub 2015 Jul 1. Review.

45.

Short History of Confidence Intervals: Or, Don't Ask "Does the Treatment Work?" but "How Sure Are You That It Works?".

Sandercock PA.

Stroke. 2015 Aug;46(8):e184-7. doi: 10.1161/STROKEAHA.115.007750. Epub 2015 Jun 23. Review. No abstract available.

PMID:
26106115
46.

Effect of Intravenous Recombinant Tissue-Type Plasminogen Activator in Patients With Mild Stroke in the Third International Stroke Trial-3: Post Hoc Analysis.

Khatri P, Tayama D, Cohen G, Lindley RI, Wardlaw JM, Yeatts SD, Broderick JP, Sandercock P; PRISMS and IST-3 Collaborative Groups.

Stroke. 2015 Aug;46(8):2325-7. doi: 10.1161/STROKEAHA.115.009951. Epub 2015 Jun 23.

PMID:
26106113
47.

A call to revolutionise acute stroke care and research.

Sandercock PA.

Lancet Neurol. 2015 Jul;14(7):674-5. doi: 10.1016/S1474-4422(15)00088-5. No abstract available.

PMID:
26067109
48.

Making randomised trials more efficient: report of the first meeting to discuss the Trial Forge platform.

Treweek S, Altman DG, Bower P, Campbell M, Chalmers I, Cotton S, Craig P, Crosby D, Davidson P, Devane D, Duley L, Dunn J, Elbourne D, Farrell B, Gamble C, Gillies K, Hood K, Lang T, Littleford R, Loudon K, McDonald A, McPherson G, Nelson A, Norrie J, Ramsay C, Sandercock P, Shanahan DR, Summerskill W, Sydes M, Williamson P, Clarke M.

Trials. 2015 Jun 5;16:261. doi: 10.1186/s13063-015-0776-0.

49.

Veronica Murray MD, PhD, 1949-2014: Specialist in Internal Medicine and Senior Scientist, Karolinska Institutet, Danderyd Hospital, Stockholm.

Sandercock P.

Int J Stroke. 2015 Jun;10(4):464. doi: 10.1111/ijs.12500. No abstract available.

PMID:
25973701
50.

Thrombolysis in acute stroke--authors' reply.

Emberson J, Lees KR, Lyden P, Baigent C, Sandercock P, Hacke W; Stroke Treatment Trialists' Collaboration.

Lancet. 2015 Apr 11;385(9976):1396. doi: 10.1016/S0140-6736(15)60718-8. No abstract available.

PMID:
25890422

Supplemental Content

Loading ...
Support Center